LIST: Guidelines for initial rollout of COVID-19 vaccines for minors

enablePagination: false
maxItemsPerPage: 10
maxPaginationLinks: 10

Metro Manila (CNN Philippines) — The country is set to expand its COVID-19 vaccination program on Oct. 15 by including minors aged 12 to 17.

The Department of Health said only minors with comorbidities - who now fall under the A3 priority group - will be part of the initial rollout. It also identified 11 pre-existing illnesses that will be considered priority.

Health Undersecretary Maria Rosario Vergeire said the Pediatric Infectious Disease Society of the Philippines listed the following illnesses:

1. Medical Complexity

2. Genetic conditions

3. Neurologic conditions

4. Metabolic / endocrine conditions

5. Cardiovascular disease

6. Obesity

7. HIV infection

8. Tuberculosis

9. Chronic respiratory disease

10. Renal disorders

11. Hepatobiliary

The minor, as well as the parent or guardian, must give an informed consent and present a medical certificate as proof of the comorbidity.

The pilot vaccination will also be limited to eight hospitals in five Metro Manila cities, Vaccine czar Carlito Galvez, Jr. said. Half of these hospitals are located in Quezon City.

The inoculation sites are:

1. National Children's Hospital (Quezon City)

2. Philippine Heart Center (Quezon City)

3. Fe Del Mundo Medical Center (Quezon City)

4. Philippine Children's Medical Center (Quezon City)

5. Pasig City Children's Hospital (Pasig)

6. Philippine General Hospital (Manila)

7. Makati Medical Center (Makati)

8. St. Luke's Medical Center (Taguig)

Galvez added the initial vaccinations may be carried out by age group, with those aged 15 to 17 first in line, followed by those aged 12 to 14.

According to Vergeire, the pilot run of pediatric vaccination will allow monitoring of possible adverse reactions among immunocompromised minors.

They will be given Pfizer and Moderna COVID-19 vaccines, the two brands with regulatory approval for minors.

The government is allocating 60 million doses for adolescents or around 26 to 29 million people, Galvez said.